Ingredient Knowledge Base

Bifidobacterium longum infantis: What It Is, Benefits, Dosage, and Sources

Nutrienting Team
15 min read

Bifidobacterium longum infantis is a specific subspecies of bacteria found in the human gut, notably prevalent in infants. It belongs to the Bifidobacterium longum species, which is a broad category of beneficial bacteria. This particular subspecies, infantis, is recognized for its unique role in the early development of the gut microbiome and its potential health benefits throughout life. Understanding its function, optimal intake, and where it can be found is key to appreciating its contribution to digestive and immune health.

Bifidobacterium longum Subspecies infantis: A Foundational Gut Resident

Bifidobacterium longum subspecies infantis, often shortened to B. infantis, is a bacterium that plays a significant role in the human gut, particularly during infancy. It's one of the first beneficial microbes to colonize the sterile infant gut, often acquired through vaginal birth and breastfeeding. Its presence is considered a hallmark of a healthy infant gut microbiome.

This subspecies is particularly adept at metabolizing human milk oligosaccharides (HMOs), complex sugars found abundantly in breast milk that are indigestible by the infant but serve as a primary food source for B. infantis. This metabolic capability provides a distinct advantage, allowing B. infantis to thrive and outcompete potentially harmful bacteria in the infant gut. The breakdown of HMOs by B. infantis produces short-chain fatty acids (SCFAs) like acetate, which contribute to a lower pH in the gut, further inhibiting the growth of pathogens.

For adults, the presence of B. infantis tends to decrease after weaning and throughout life, although it can still be found in varying amounts. Its ability to interact with the immune system and gut lining, even in smaller quantities, suggests ongoing potential benefits beyond infancy. For example, some research points to its role in modulating inflammatory responses and maintaining gut barrier integrity. The practical implication is that while it's foundational for infants, its benefits might extend to adults facing certain gut-related challenges.

Consider a scenario where an infant is not breastfed. Their gut microbiome often develops differently, sometimes lacking the high levels of B. infantis seen in breastfed infants. This difference has led to the development of infant formulas supplemented with probiotics, including B. infantis, to attempt to mimic some of the benefits of breastfeeding on gut development. However, it's important to recognize that formula supplementation, while beneficial, cannot fully replicate the complex biochemical and immunological profile of breast milk.

Bifidobacterium Longum Subsp. Infantis: An Overview of Its Mechanisms

To understand what is Bifidobacterium longum infantis, it's helpful to look at its mechanisms within the gut. Beyond simply occupying space, B. infantis actively contributes to a healthy gut environment through several pathways.

One primary mechanism is its exceptional ability to break down HMOs. These complex carbohydrates aren't just food for B. infantis; their fermentation by this bacterium produces a range of beneficial compounds. These include SCFAs, which nourish gut cells, provide an energy source for the host, and contribute to an acidic environment that deters pathogens. This process is crucial for preventing the colonization of harmful bacteria and promoting overall gut health.

B. infantis also interacts directly with the host's immune system. It can help regulate immune responses, potentially reducing inflammation in the gut. This is particularly relevant in conditions characterized by gut inflammation. By strengthening the gut barrier, B. infantis may prevent the translocation of toxins and undigested food particles from the gut into the bloodstream, a phenomenon sometimes referred to as "leaky gut."

The bacterium also produces certain vitamins, such as B vitamins, which are important for various bodily functions. While the exact contribution of B. infantis to the host's vitamin supply is still being researched, it highlights the multifaceted role of beneficial gut bacteria.

An edge case for B. infantis involves individuals with specific genetic predispositions or dietary patterns. For example, some people may have gut microbiomes that naturally support higher levels of B. infantis even without direct supplementation, while others may struggle to maintain it. This suggests that while supplementation can be beneficial, individual responses can vary based on the existing gut ecosystem and host genetics.

Bifidobacterium longum infantis: Benefits Across the Lifespan

The benefits associated with Bifidobacterium longum infantis extend beyond early infancy, although its role is most pronounced during that period. Understanding these benefits helps clarify what is Bifidobacterium longum infantis and why it's considered a valuable probiotic.

For Infants:

  • Enhanced Gut Microbiome Development: As discussed, it's crucial for establishing a healthy gut flora, especially in breastfed infants, by metabolizing HMOs.
  • Reduced Risk of Infections: By producing an acidic environment and competing with pathogens, it can help prevent common infant infections.
  • Immune System Modulation: Early colonization with B. infantis is associated with a more balanced immune response, potentially reducing the risk of allergies and autoimmune conditions later in life.
  • Improved Digestion: Its metabolic activities aid in the digestion and absorption of nutrients from breast milk.

For Adults:

While its prevalence naturally declines after infancy, research suggests that supplementing with B. infantis can still offer benefits for adults, particularly concerning gut health and immune function.

  • Irritable Bowel Syndrome (IBS) Symptom Relief: Some studies indicate that B. infantis supplementation can help alleviate symptoms of IBS, such as abdominal pain, bloating, and discomfort. This is often attributed to its anti-inflammatory properties and its ability to modulate gut sensation.
  • Inflammatory Bowel Disease (IBD) Support: For individuals with IBD (e.g., Crohn's disease, ulcerative colitis), B. infantis may help reduce inflammation and support gut barrier function, potentially aiding in symptom management and remission maintenance. However, it's not a cure and should be used under medical guidance.
  • Improved Mood and Stress Response: Emerging research in the gut-brain axis suggests that a healthy gut microbiome, supported by beneficial bacteria like B. infantis, can influence mood and stress levels.
  • Enhanced Immune Function: By interacting with gut-associated lymphoid tissue (GALT), B. infantis can contribute to a robust immune system, helping the body defend against various threats.

It's important to note that the efficacy of B. infantis can vary depending on the specific strain used in supplements. For example, the strain Bifidobacterium longum subsp. infantis 35624 (sometimes referred to as Bifidobacterium infantis 35624) has been particularly well-studied for its effects on IBS symptoms. This highlights the importance of looking beyond just the species name to the specific strain when considering probiotic supplements.

Bifidobacterium Infantis: Benefits, Side Effects, and More

Delving deeper into Bifidobacterium infantis reveals a nuanced picture of its potential. While its benefits are compelling, understanding potential side effects and appropriate usage is equally important.

Potential Benefits in Detail

As touched upon, the benefits stem largely from its ability to process complex carbohydrates and interact with the immune system.

  • Gut Health and Digestion:

* HMO Metabolism: In infants, this is paramount. For adults, it can still contribute to the fermentation of other complex fibers, producing beneficial SCFAs.

Gut Barrier Integrity: B. infantis* can help strengthen the tight junctions between gut cells, reducing gut permeability and preventing unwanted substances from entering the bloodstream. This is a critical aspect of overall gut health.

* Pathogen Inhibition: By producing lactic acid and acetic acid, it creates an acidic environment that is unfavorable for many harmful bacteria, effectively crowding them out.

  • Immune System Support:

Anti-inflammatory Effects: Studies suggest that B. infantis* can reduce levels of pro-inflammatory cytokines while potentially increasing anti-inflammatory ones. This modulation can be beneficial in conditions involving chronic inflammation.

* Immune System Maturation: In infants, it plays a role in the proper development and training of the immune system, potentially influencing long-term immune health.

  • Mental Well-being (Gut-Brain Axis):

Research indicates a connection between gut microbiota composition and mental health. B. infantis* has been explored for its potential to reduce stress-induced inflammation and improve mood, though this area requires more comprehensive human trials.

Possible Side Effects

Generally, B. infantis is considered safe for most people, especially when consumed in food sources or standard probiotic supplements. Side effects are typically mild and transient.

  • Digestive Discomfort: Some individuals may experience temporary bloating, gas, or mild abdominal discomfort when first starting a B. infantis supplement. This is often a sign of the gut microbiome adjusting to the new bacteria and usually subsides within a few days or weeks.
  • Allergic Reactions: While rare, allergic reactions to probiotic ingredients (e.g., fillers, binders) are possible. If you have known allergies, check the ingredient list carefully.
  • Systemic Infection (Extremely Rare): In individuals who are severely immunocompromised or have compromised gut barriers (e.g., critically ill patients, those with central venous catheters), there is an extremely rare theoretical risk of probiotics entering the bloodstream and causing systemic infection. This is not a concern for healthy individuals.

Contraindications

While generally safe, certain groups should exercise caution or consult a healthcare professional before taking B. infantis supplements:

  • Severely Immunocompromised Individuals: As mentioned, those with severely weakened immune systems should be cautious.
  • Individuals with Pancreatitis: Some research suggests probiotics might not be beneficial in acute severe pancreatitis.
  • Individuals with Short Bowel Syndrome: These individuals may have altered gut environments that could react differently to probiotics.
  • Infants with Specific Health Conditions: While beneficial for healthy infants, those with serious underlying health issues should only receive probiotics under medical supervision.

Comparison of B. infantis vs. Other Common Probiotic Strains

To put B. infantis into context, it's useful to compare its primary roles with other well-known probiotic strains.

Feature / StrainBifidobacterium longum infantis (e.g., 35624)Lactobacillus rhamnosus GG (LGG)Saccharomyces boulardii (Yeast)
Primary FocusInfant gut development, IBS symptoms, inflammation modulationDiarrhea prevention (antibiotic-associated, traveler's), immune supportDiarrhea treatment (antibiotic-associated, C. difficile), gut barrier support
Metabolic NicheExcellent at fermenting HMOs (infants), general fiber fermentation (adults)Ferments various carbohydrates, produces lactic acidDoes not colonize, produces polyamines, enzymes, and short-chain fatty acids
Immune InteractionStrong anti-inflammatory effects, immune system trainingModulates immune response, enhances IgA productionAnti-inflammatory, anti-toxin effects
Common Use CasesInfant gut health, IBS, IBD support, moodAntibiotic-associated diarrhea, common colds, eczema preventionAcute diarrhea, C. difficile infection, traveler's diarrhea
Typical Side EffectsMild gas/bloating initiallyMild gas/bloating initiallyMild gas/bloating, constipation (rare)
Survival in GutGood survival, transient colonizationGood survival, transient colonizationGood survival, transient passage
Antibiotic ResistanceGenerally susceptible to common antibiotics (important for medical treatment)Generally susceptible, but some strains may have intrinsic resistanceIntrinsically resistant to antibacterial antibiotics (as it's a yeast)

This table illustrates that while all are beneficial, their strengths and specific applications can differ significantly. B. infantis stands out for its foundational role in infancy and its specific utility in managing inflammatory gut conditions like IBS.

Genomic Atlas of Bifidobacterium infantis and B. longum: The Science Behind the Strain

The genomic understanding of Bifidobacterium infantis and Bifidobacterium longum provides deeper insights into what is Bifidobacterium longum infantis and its unique capabilities. Genomics, the study of an organism's entire genetic material, allows scientists to map out the specific genes that confer particular traits to these bacteria.

Comparing the genomes of B. infantis with other B. longum subspecies reveals key genetic differences that explain B. infantis's specialized functions. For instance, B. infantis possesses a greater number of genes dedicated to the metabolism of complex carbohydrates, particularly HMOs. These genes encode enzymes that are specifically adapted to break down these intricate breast milk sugars, a capability not as pronounced in other Bifidobacterium strains or even other B. longum subspecies. This genetic blueprint confirms its evolutionary adaptation to the infant gut environment.

The genomic atlas also highlights genes involved in adhesion to the gut lining, resistance to stomach acid and bile, and the production of beneficial metabolites like SCFAs and certain vitamins. Understanding these genetic elements helps explain B. infantis's resilience and its ability to exert its probiotic effects.

Furthermore, genomic studies have helped differentiate various strains within B. infantis. For example, the specific strain Bifidobacterium longum subsp. infantis 35624 (often simply called B. infantis 35624) has been extensively sequenced and studied, revealing its particular genetic makeup that contributes to its efficacy in conditions like IBS. This genomic precision allows for targeted research and development of probiotic products.

A practical implication of this genomic knowledge is the ability to select the most effective strains for specific health outcomes. Instead of a generic "probiotic," the industry can now focus on strain-specific benefits, ensuring that consumers receive a product with a higher likelihood of delivering desired results. This genomic approach also aids in quality control and authentication of probiotic products, ensuring that the advertised strain is indeed present.

What is Bifidobacterium infantis? – Sources and Dosage

Understanding what is Bifidobacterium infantis also involves knowing where to find it and how much to take for potential benefits.

Natural Sources

While B. infantis is a natural resident of the human gut, especially in infants, it's not commonly found in significant amounts in fermented foods in the same way Lactobacillus species are.

  • Breast Milk: The primary natural source for infants, as breast milk contains HMOs that selectively nourish B. infantis.
  • Gut Microbiome: Healthy individuals, especially infants, naturally harbor B. infantis as part of their gut flora. However, its levels can be influenced by diet, lifestyle, and antibiotic use.

Unlike Lactobacillus strains often found in yogurt, kefir, or sauerkraut, B. infantis is not typically a prominent bacterium in these fermented products. Therefore, for adults seeking to increase their B. infantis levels, supplementation is often the most direct route.

Supplementation: Bifidobacterium longum infantis Supplement

B. infantis is available as a standalone probiotic supplement or as part of multi-strain probiotic formulations. When choosing a supplement, consider the following:

  • Strain Specificity: Look for products that specify the strain, such as Bifidobacterium longum subsp. infantis 35624, which has robust scientific backing.
  • CFUs (Colony Forming Units): This indicates the number of live bacteria per dose.
  • Delivery System: Some supplements use delayed-release capsules to protect the bacteria from stomach acid, ensuring more live bacteria reach the intestines.
  • Third-Party Testing: Look for supplements that have been independently tested for purity and potency.

Dosage Recommendations: Bifidobacterium longum infantis Dosage

Probiotic dosing is often measured in CFUs. There isn't a universally established "recommended daily allowance" for B. infantis, as optimal dosage can vary depending on the specific strain, the intended health benefit, and individual factors.

  • For Infants: Specific infant probiotic drops or powders often contain B. infantis in dosages ranging from 1 billion to 10 billion CFUs. These are typically formulated for infant safety and efficacy.
  • For Adults (e.g., IBS symptoms): Studies investigating B. infantis 35624 for IBS have often used dosages in the range of 1 billion to 10 billion CFUs per day. Some products may contain higher amounts, but it's not always clear if higher doses provide additional benefit.
  • General Gut Health: For general maintenance, a daily dose within the 1 billion to 10 billion CFU range is commonly found in supplements.

It's advisable to follow the dosage instructions provided by the supplement manufacturer or, ideally, consult with a healthcare professional, especially if you are addressing a specific health condition. They can help determine the appropriate dosage and duration of use for your individual needs. Starting with a lower dose and gradually increasing it can also help minimize potential initial digestive discomfort.

FAQ

What is the best source of bifidobacterium infantis?

For infants, the best natural source is breast milk, which contains human milk oligosaccharides (HMOs) that B. infantis specifically ferments to thrive. For adults, B. infantis is not commonly found in high concentrations in fermented foods like yogurt or kimchi. Therefore, the most direct way for adults to increase their intake is through targeted probiotic supplements that specifically contain Bifidobacterium longum subsp. infantis, often a well-researched strain like 35624.

Who should not take Bifidobacterium longum?

While generally safe for most healthy individuals, certain groups should exercise caution or avoid Bifidobacterium longum (and other probiotics) without medical consultation. This includes individuals who are severely immunocompromised (e.g., organ transplant recipients, those undergoing chemotherapy, critical care patients), those with a compromised gut barrier, or individuals with a history of systemic infection related to probiotics. People with acute pancreatitis or short bowel syndrome should also consult a healthcare professional.

What does bifidobacterium infantis do for the body?

Bifidobacterium infantis contributes to several important bodily functions, primarily centered around gut health and immune modulation. In infants, it helps establish a healthy gut microbiome by metabolizing human milk oligosaccharides, producing beneficial short-chain fatty acids, and inhibiting the growth of harmful bacteria. For adults, it can help alleviate symptoms of Irritable Bowel Syndrome (IBS), reduce gut inflammation, strengthen the gut barrier, and support overall immune function by interacting with gut-associated lymphoid tissue. It may also play a role in the gut-brain axis, potentially influencing mood and stress response.

Conclusion

Bifidobacterium longum infantis stands out as a significant beneficial bacterium, particularly for its foundational role in early life and its continued, albeit diminished, presence and potential benefits in adulthood. Its unique ability to metabolize human milk oligosaccharides highlights its evolutionary adaptation and its contribution to a healthy infant gut. For adults, it has shown promise in managing inflammatory gut conditions like IBS and supporting overall digestive and immune health. When considering supplementation, paying attention to specific strains and consulting with a healthcare provider can help ensure its appropriate and effective use.

Nutrienting Team

The Nutrienting editorial team analyzes supplement labels from the NIH Dietary Supplement Label Database and scores them against clinical research. Our goal is to help you make data-driven supplement decisions.

Related Articles